October 2025
The global SGLT-2 inhibitors market size is estimated to hit around USD 31.34 billion by 2034 increasing from USD 18.18 billion in 2025, with a CAGR of 6.24%.
June 2026
The global calcineurin inhibitors market size was evaluated at USD 10.42 billion in 2025 and is predicted to hit around USD 20.88 billion by 2035, growing at a CAGR of 7.20%.
April 2026
The global proton pump inhibitors market size is estimated to hit around USD 7.33 billion by 2035 increasing from USD 4.29 billion in 2025, with a CAGR of 5.50%.
April 2026
The global immune checkpoint inhibitors market size is predicted to hit around USD 258.91 billion by 2035 from USD 58.53 billion in 2025 with a CAGR of 16.03%.
March 2026
The global paraffin inhibitors market size was valued at USD 737.81 million in 2025 and is projected to hit around USD 1,180.61 million by 2035, at a CAGR of 4.81%.
February 2026
The interleukin inhibitors market size was exhibited at USD 30.62 billion in 2025 and is expected to surpass around USD 93.68 billion by 2035 with a CAGR of 11.83%.
February 2026
The global cell cycle inhibitors market size was evaluated at USD 5.72 billion in 2025 and is predicted to hit around USD 11.50 billion by 2035, growing at a CAGR of 7.23%.
February 2026
The global bone resorption inhibitors market size was evaluated at USD 3.87 billion in 2025 and is predicted to hit around USD 7.48 billion by 2035, growing at a CAGR of 6.82%.
February 2026
The global VMAT2 inhibitors market size was evaluated at USD 6.04 billion in 2025 and is predicted to hit around USD 15.29 billion by 2035, growing at a CAGR of 9.74%.
September 2025
The global C5 complement inhibitors market size is estimated to hit around USD 16.01 billion by 2034 increasing from USD 4.25 billion in 2024, with a CAGR of 14.18%.
August 2025
The global clean label mold inhibitors market size reached USD 1.14 billion in 2024 and is projected to be worth around USD 2.24 billion by 2034, with a notable CAGR of 6.93%.
July 2025
The global corrosion inhibitors market size was estimated at USD 8.82 billion in 2024 and is projected to surge around USD 13.34 billion by 2034, with a CAGR of 4.22%.
July 2025
The global lipase inhibitors obesity drugs market size was estimated at USD 1.25 billion in 2024 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
January 2025
The global KRAS inhibitors market size is calculated at USD 118.26 million in 2025 and is projected to hit around USD 190.92 million by 2035 with a CAGR of 4.93%
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com